BPC 157 Mark Hyman, MD Attia, Huberman, and Rogan: Insights on Hormones, Peptides, and Supplements (*EXTENDED VERSION: what each podcaster takes and why*) Andrew Huberman consults an expert to address concerns about the potential risks of peptides BPC 157 and TB 500, particularly their possible link to tumor growth. >> Full story Peptides take off in the fitness industry, from gyms to personal trainers, despite a lack of large scale human trials Chinese Peptides' Are the Latest Biohacking Trend in the Tech World The New York Times Renowned neuroscientist Andrew Huberman shares his personal experiences with experimental supplements and therapies, including BPC 157 and NMN. >> See comments for full story